Managed Healthcare Executive December 7, 2022
Susan Ladika

Cuban’s Cost Plus Drugs business has entered into agreements with Capital Blue Cross and Rightway.

Billionaire Mark Cuban’s Cost Plus Drugs venture, which is aimed at offering low-priced generic drugs, is gradually gaining traction, signing its first agreement with a health insurance company. Capital Blue Cross in Harrisburg, Pennsylvania, announced in October that it was teaming up with Cost Plus Drugs, because the payer “is always looking for ways to control costs for our members and employer groups,” Samir Mistry, Pharm.D., MBA, vice president of pharmacy strategy and services at Capital Blue Cross, said in an email.

Capital Blue Cross approached Cuban’s company to help provide “another option for people to obtain affordable medications,” Mistry said. “We want to increase...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
Will The White House’s Plan To Curb Drug Shortages Work?
Pharma Pulse 4/24/24: 5 Things You Should Know About Women's Health, Microsoft Makes Push Into Smaller AI Systems & more
New AI drug discovery powerhouse Xaira rises with $1B in funding
AI-enabled drug discovery company Xaira launches with $1B
25 most expensive hospital drugs

Share This Article